$7 billion prescription market, but good luck with the OTC stuff. I have no idea if the trial will work, but even at a $20 million cap that seems low if they get an IND. Generally market caps get bump ups for milestones, we should know within a few months whether they can skip phase 1 and go into phase 2. The patent and FDA lawyer is sharp, he was the attorney for the only other CBD drug that was approved. His father was the CEO at Roche for almost 20 years I think.
The value of the retail gum and the VTGN could almost be worth the market cap. My crystal ball on predicting stock prices is broken. VTGN was struggling for years and finally firms put in $100 million that was not there a month ago.
Blink is done, Taug position sold. We personally did very well on BLNK also I think TAUG did as well. At $55 I was going to buy puts...Missed that boat but it still seems way overvalued. Taug holds about $100k position in Serendipity Brands. Last I checked the valuation was up about 400 percent. But it is a private company. We are a large shareholder there and are plan on a 3-5 yr hold.. Taug has about 1.1 million position in VTGN. Some shares, some .50 warrants and 200k $1.50 warrants. That could get very interesting, but who knows.
As far as TAUG future, my hope is that the pharma has value. I was against this whole CBD adventure but after taking the gum for over a week it helped me quite a bit from a 30 yr issue from being hit head on. I think it is great for reducing inflammation as are other natural products.
If you are on the fence about the stock move on. Not worth stressing or worrying. Try the gum though, or another high quality CBD product for your health. Get an inflammation test and then get another one in a year. Anyway, good
News 
Market Data 
Discover 
